Totally implantable venous access devices
implantation by cut-down or the puncture method was performed in the same fashion.
Managing Patients With Central Venous Access Devices
in 1979 which was subsequently modified and replaced by Broviac catheter.1 Since then, Hickman and Broviac catheters are being used most commonly.1,2 Central venous access devices
are needed in the management of patients who need frequent blood products, antibiotics, blood sampling, prolonged surgical nutrition and chemotherapy.3-5 These catheters are tunnelled under the skin, but have an external exit site which require local care and is associated with a relatively high complication rate.6 Alternative devices have been developed in the hope of improving safety and acceptability.
Catheter tip position in the analysis on central venous access device
Wendy Jar is a Clinical Nurse Specialist in the Bone Marrow Transplant Unit at Christchurch District Health Board (CDHB) and is also involved in the on-going evolution of Central Venous Access Device
Recombinant tissue plasminogen activator for central venous access device
It is estimated that approximately 93% of patients receiving home intravenous therapies have a long-term central venous access device
(CVAD) in place (Herbst, Kaplan, & McKinnon, 1998).
Venous access devices
are ubiquitous within the healthcare system.
An afternoon of pre-conference master-classes focused on central venous access devices
, wound care and pharmacology.
Totally Implantable Venous Access Devices
Implanted Surgically: A Retrospective Study on Early and Late Complications.
Prevalence of the use of central venous access devices
within and outside of the intensive care unit: results of a survey among hospitals in the Prevention Epicenter Program of the Centers for Disease Control and Prevention.